The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
RNA-seq (gene expression) · human · 64 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 64 samples: 20 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma modelsNeuro-oncology · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255972_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1077325 and SRA study SRP460562. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 64 samples.
How we read this: 20 replicated groups read from 64 sample titles; they account for 64 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7780938 CHLA03_C_1 CHLA03_C
- GSM7780939 CHLA03_D24RGD_1 CHLA03_D24RGD
- GSM7780940 CHLA03_ONC201_1 CHLA03_ONC201
- GSM7780941 CHLA03_D24RGDONC201_1 CHLA03_D24RGDONC201
- GSM7780942 CHLA03_C_2 CHLA03_C
- GSM7780943 CHLA03_D24RGD_2 CHLA03_D24RGD
- GSM7780944 CHLA03_ONC201_2 CHLA03_ONC201
- GSM7780945 CHLA03_D24RGDONC201_2 CHLA03_D24RGDONC201
- GSM7780946 CHLA03_C_3 CHLA03_C
- GSM7780947 CHLA03_D24RGD_3 CHLA03_D24RGD
- GSM7780948 CHLA03_ONC201_3 CHLA03_ONC201
- GSM7780949 CHLA03_D24RGDONC201_3 CHLA03_D24RGDONC201
- GSM7780950 TP54_C_1 TP54_C
- GSM7780951 TP54_D24RGD_1 TP54_D24RGD
- GSM7780952 TP54_ONC201_1 TP54_ONC201
- GSM7780953 TP54_D24RGDONC201_1 TP54_D24RGDONC201
- GSM7780954 TP54_C_2 TP54_C
- GSM7780955 TP54_D24RGD_2 TP54_D24RGD
- GSM7780956 TP54_ONC201_2 TP54_ONC201
- GSM7780957 TP54_D24RGDONC201_2 TP54_D24RGDONC201
- GSM7780958 TP54_C_3 TP54_C
- GSM7780959 TP54_D24RGD_3 TP54_D24RGD
- GSM7780960 TP54_ONC201_3 TP54_ONC201
- GSM7780961 TP54_D24RGDONC201_3 TP54_D24RGDONC201
- GSM7780962 TP54_C_4 TP54_C
- GSM7780963 TP54_D24RGD_4 TP54_D24RGD
- GSM7780964 TP54_ONC201_4 TP54_ONC201
- GSM7780965 TP54_D24RGDONC201_4 TP54_D24RGDONC201
- GSM7780966 SJGBM2_C_1 SJGBM2_C
- GSM7780967 SJGBM2_D24RGD_1 SJGBM2_D24RGD
- GSM7780968 SJGBM2_ONC201_1 SJGBM2_ONC201
- GSM7780969 SJGBM2_D24RGDONC201_1 SJGBM2_D24RGDONC201
- GSM7780970 SJGBM2_C_2 SJGBM2_C
- GSM7780971 SJGBM2_D24RGD_2 SJGBM2_D24RGD
- GSM7780972 SJGBM2_ONC201_2 SJGBM2_ONC201
- GSM7780973 SJGBM2_D24RGDONC201_2 SJGBM2_D24RGDONC201
- GSM7780974 SJGBM2_C_3 SJGBM2_C
- GSM7780975 SJGBM2_D24RGD_3 SJGBM2_D24RGD
- GSM7780976 SJGBM2_ONC201_3 SJGBM2_ONC201
- GSM7780977 SJGBM2_D24RGDONC201_3 SJGBM2_D24RGDONC201
+ 24 more — browse all 64 samples with per-sample file links →
- GSE266919 Distinct Cellular Mechanisms Underlie Chemotherapies and Their Combinations with PD-L1 Checkpoint Inhibitor in Triple-Negative Breast Cancer [TNBC] 117 samples shares combination
- GSE315130 Differential mRNA expression analysis of multiple human and mouse pancreatic cancer cells and tumors after DMSO, tazemetostat, RMC-6236, or the combination treatment. 67 samples shares combination
- GSE317309 Combination of a CCL21-gene modified dendritic cell vaccine and pembrolizumab induces immune responses in non-small cell lung cancer 64 samples shares combination
- GSE260599 Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors 61 samples shares combination
- GSE251918 Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations [RNA-seq] 8 samples shares combination
- GSE301188 Envafolimab and Chidamide in combination with GEMOX as first-line treatment for advanced and metastatic biliary tract cancer (B-Enefits/SCOG-B001): A single-arm, exploratory, phase 2 trial 6 samples shares combination
- GSE313963 Transposase-assisted in situ capture of recombination DSB hotspots (TAID-seq) [CUT&Tag] 45 samples shares combination
- GSE251920 Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations 18 samples shares combination
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.